Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04655144 · ClinicalTrials.gov registry record · Phase 3
Dexamethasone for Post Uterine Artery Embolization Pain
A Phase 3 study, sponsored by University of Miami.
- Completed
- Registry status
- Phase 3
- Development phase
- 42
- Enrollment target
NCT04655144 is a Phase 3 study that has completed, run by University of Miami. The registered enrollment target is 42 participants.
The verdict
NCT04655144, a Phase 3 study, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 42 participants
- Enrollment target
Study Summary
The purpose of this research is to investigate if administration steroids (anti-inflammatory medication) via the uterine arteries during uterine fibroid embolization (A non surgical procedure for treating uterine fibroids by blocking their blood supply) can help reduce the pain, nausea, vomiting, and general feeling of weakness following the procedure.
Interventions
- DRUG Dexamethasone
- DRUG Saline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2021-01-25 |
| Est. Completion | 2024-12-04 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04655144
The ClinicalTrials.gov registry entry for NCT04655144 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Dexamethasone is the first listed.
NCT04655144 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04655144 about?
NCT04655144 is a clinical study titled "Dexamethasone for Post Uterine Artery Embolization Pain". The purpose of this research is to investigate if administration steroids (anti-inflammatory medication) via the uterine arteries during uterine fibroid embolization (A non surgical procedure for treating uterine fibroids by blocking their blood supply) can help reduce the pain, nausea, vomiting, an...
What is the current status of trial NCT04655144?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 42 participants. The study started on 2021-01-25. Estimated completion is 2024-12-04.
What interventions are being tested in trial NCT04655144?
The interventions under investigation include: Dexamethasone (DRUG), Saline (DRUG).
Who is sponsoring clinical trial NCT04655144?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.